Biodegradable Stents - Global Market Outlook (2016-2022)

The Global Biodegradable Stents market accounted for $0.47 billion in 2016 and is expected to reach $3.51 billion by 2022 growing at a CAGR of 39.8% during the forecast period 2016 to 2022. The prevailing usage of stents in the treatment of artery disease is rapidly providing market growth. Patient's demands for minimal invasive surgeries, a growing geriatric population and technological advancements are some of the factors driving the market. However, safety & regulatory issues and cost issues are some reasons behind the market lag.
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

The Global Biodegradable Stents market accounted for $0.47 billion in 2016 and is expected to reach $3.51 billion by 2022 growing at a CAGR of 39.8% during the forecast period 2016 to 2022. The prevailing usage of stents in the treatment of artery disease is rapidly providing market growth. Patient's demands for minimal invasive surgeries, a growing geriatric population and technological advancements are some of the factors driving the market. However, safety & regulatory issues and cost issues are some reasons behind the market lag.

The hospitals segment is expected to dominate the market, because of the majority of hospitals procuring medical products and consumables in bulk. Moreover, coronary artery disease is expected to dominate the application segment on account of a growing geriatric population and rising consequences of disease occurring. North America is estimated to dominate the market due to a high prevalence of cardiovascular diseases. In addition to that, the Asia Pacific market is expected to grow at the highest CAGR attributing to a growing awareness about bioabsorbable stents.

Some of the key players of the Biodegradable Stents market include Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, Arterius Limited, BIOTRONIK SE & Co. KG, Biotronik, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Meril Life Sciences, REVA Medical, Inc., SMT (Part of Sahajanand Group of Companies), Tepha, Inc. and Xenogenics Corporation.

End-Users Covered:

Applications Covered:

Materials Covered:

Drugs covered:

Absorption Rates covered:

Regions Covered:

What The Report Offers:

Key Topics Covered:

1. Executive Summary
2. Preface
3. Market Trend Analysis
4. Porters Five Force Analysis
5. Global Biodegradable Stents Market, By End-User
6. Global Biodegradable Stents Market, By Application
7. Global Biodegradable Stents Market, By Material
8. Global Biodegradable Stents Market, By Drug
9. Global Biodegradable Stents Market, By Absorption Rate
10. Global Biodegradable Stents Market, By Geography
11. Key Developments
12. Company Profiling

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/42z32n/biodegradable?w=5

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Per maggiori informazioni

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;